Literature DB >> 27094404

Evaluation of the 'Jumping to conclusions' bias in different subgroups of the at-risk mental state: from cognitive basic symptoms to UHR criteria.

F Rausch1, S Eisenacher1, H Elkin1, S Englisch1, S Kayser2, N Striepens2, M Lautenschlager3, A Heinz3, Y Gudlowski3, B Janssen4, W Gaebel4, T M Michel5, F Schneider5, M Lambert6, D Naber6, G Juckel7, S Krueger-Oezguerdal7, T Wobrock8, A Hasan9, M Riedel9, S Moritz6, H Müller10, J Klosterkötter10, A Bechdolf10, M Zink1, M Wagner2.   

Abstract

BACKGROUND: Patients with psychosis display the so-called 'Jumping to Conclusions' bias (JTC) - a tendency for hasty decision-making in probabilistic reasoning tasks. So far, only a few studies have evaluated the JTC bias in 'at-risk mental state' (ARMS) patients, specifically in ARMS samples fulfilling 'ultra-high risk' (UHR) criteria, thus not allowing for comparisons between different ARMS subgroups.
METHOD: In the framework of the PREVENT (secondary prevention of schizophrenia) study, a JTC task was applied to 188 patients either fulfilling UHR criteria or presenting with cognitive basic symptoms (BS). Similar data were available for 30 healthy control participants matched for age, gender, education and premorbid verbal intelligence. ARMS patients were identified by the Structured Interview for Prodromal Symptoms (SIPS) and the Schizophrenia Proneness Instrument - Adult Version (SPI-A).
RESULTS: The mean number of draws to decision (DTD) significantly differed between ARM -subgroups: UHR patients made significantly less draws to make a decision than ARMS patients with only cognitive BS. Furthermore, UHR patients tended to fulfil behavioural criteria for JTC more often than BS patients. In a secondary analysis, ARMS patients were much hastier in their decision-making than controls. In patients, DTD was moderately associated with positive and negative symptoms as well as disorganization and excitement.
CONCLUSIONS: Our data indicate an enhanced JTC bias in the UHR group compared to ARMS patients with only cognitive BS. This underscores the importance of reasoning deficits within cognitive theories of the developing psychosis. Interactions with the liability to psychotic transitions and therapeutic interventions should be unravelled in longitudinal studies.

Entities:  

Keywords:  At-risk mental state; jumping-to-conclusion; metacognition; probabilistic reasoning; prodrome; schizophrenia

Mesh:

Year:  2016        PMID: 27094404     DOI: 10.1017/S0033291716000465

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  5 in total

Review 1.  Dual-process theory, conflict processing, and delusional belief.

Authors:  Michael V Bronstein; Gordon Pennycook; Jutta Joormann; Philip R Corlett; Tyrone D Cannon
Journal:  Clin Psychol Rev       Date:  2019-06-12

Review 2.  The Importance of Metamemory Functioning to the Pathogenesis of Psychosis.

Authors:  Sarah Eisenacher; Mathias Zink
Journal:  Front Psychol       Date:  2017-03-06

3.  The Relation between Negative Automatic Thoughts and Psychological Inflexibility in Schizophrenia.

Authors:  Cosmin O Popa; Adrian V Rus; Wesley C Lee; Cristiana Cojocaru; Alina Schenk; Vitalie Văcăraș; Peter Olah; Simona Mureșan; Simona Szasz; Cristina Bredicean
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.241

4.  Beta-Blocker Propranolol Modulates Decision Urgency During Sequential Information Gathering.

Authors:  Tobias U Hauser; Michael Moutoussis; Nina Purg; Peter Dayan; Raymond J Dolan
Journal:  J Neurosci       Date:  2018-07-13       Impact factor: 6.709

5.  Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis.

Authors:  Ana Catalan; Stefania Tognin; Matthew J Kempton; Daniel Stahl; Gonzalo Salazar de Pablo; Barnaby Nelson; Christos Pantelis; Anita Riecher-Rössler; Rodrigo Bressan; Neus Barrantes-Vidal; Marie-Odile Krebs; Merete Nordentoft; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Jim van Os; Lieuwe de Haan; Mark van der Gaag; Lucia R Valmaggia; Philip McGuire
Journal:  Psychol Med       Date:  2020-10-06       Impact factor: 10.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.